EPPENDORF SE

Company Snapshot

Founded: 1945
Entity Type: Private
Employees: 4,658
Region: Americas
Revenue: $1,060.9 Millions
Revenue Year: 2024
Headquarter: Hamburg, Germany
Key Geographics: Americas, Europe, Asia-Pacific, Africa, China
Corporate Address: Barkhausenweg 1 22339 Hamburg Germany Tel: +49-40-53-801-0 www.eppendorf.com

Company Overview

Eppendorf SE, a life science company, manufactures and sells instruments and consumables, and it provides services for liquid, sample, and cell handling. It produces liquid handling systems, pipetting systems, and cell handling products, such as bioreactors, fermenters, single-use reactors, ultra-low temperature freezers, and cell manipulation systems. It offers sample handling products, such as centrifuges, vacuum concentrators, rotors, thermo-mixers, PCR devices, temperature control systems, and others. Its products are used in academic and commercial research laboratories, pharmaceutical and biotechnological companies, and the chemical and food industries.

Eppendorf SE manufactures single-use vessel portfolio, such as BioBLU 10c single-use vessels and DASGIP overhead drives. These products have applications in insect, mammalian, and human suspension cell cultures and in adherent cell line development. It provides single-use bioreactors used in the determination of the oxygen mass transfer coefficient (kLa).

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

EPPENDORF SE In Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Analysis of the global single-use technologies for biopharmaceuticals market, covering technologies, components, applications, end users, patents and competitive insights through 2031.

Separation Systems for Commercial Biotechnology

According to BCC Research detailed report on Separation Systems for Commercial Biotechnology market report includes global revenue ($ million) for base year data 2024, estimated data for 2025, and forecast data for 2026...

Bioprocess Optimization and Digital Bio-manufacturing: Global Markets

BCC Research Market Analyst says global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029

Company's Business Segments

  • Separation and Instrumentation : Centrifuges, Ultra-low-temperature (ULT) freezers, PCR thermal cyclers
  • Liquid Handling : Pipettes and pipetting aids, Pipette manager (connected pipettes), Automated pipetting systems
  • Consumables : Sample tubes, Pipette tips, Multiwell plates
  • Lab Solutions (Bioprocess and Digital) : Bioreactors, Bioprocess control systems, Bioprocess Autosampler

Applications/End User Industries

  • Biotechnology
  • Pharmaceuticals
  • Clinical Diagnostics
  • Academic Research
  • Environmental Testing
  • Food and Beverage
AI Sentiment